IDORSIA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

IDORSIA Trademark

Serial Number: 79214844 • Registration: 5516089

IDORSIA is a trademark filed by Idorsia Pharmaceuticals Ltd on July 6, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Idorsia Pharmaceuticals Ltd (33 trademarks)

Hegenheimermattweg 91

Entity Type: 99

Trademark Details

Filing Date

July 6, 2017

Registration Date

July 17, 2018

Published for Opposition

May 1, 2018

Goods & Services

Medical services [ ; veterinary services; hygienic and beauty care for human beings or animals ]

Scientific and technological services, namely, research and design services in the field of pharmaceuticals; industrial analysis and research services in the pharmaceutical industry [ ; design and development of computer hardware and software ]

Pharmaceutical, medical [ and veterinary ] preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, [ cancer, ] auto-immune disorders, neurodegenerative diseases, diseases of the central nervous system [ , glycolipid storage disorders, and allergic diseases; sanitary preparations for medical purposes; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; food supplements for humans and animals; plasters, namely, medical plasters, and materials for dressings, namely, adhesive plasters for medical purposes; disinfectants; fungicides ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 22, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 22, 2025 71AG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 22, 2025 71AG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2025 NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 22, 2025 71AG
REGISTERED-SEC.71 ACCEPTED
May 22, 2025 71AG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 22, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 19, 2025 APRE
TEAS SECTION 71 RECEIVED
Jan 16, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 17, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 30, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 30, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2018 R.PR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
May 9, 2018 CORR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 1, 2018 PUBO
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 27, 2018 CRCV
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 26, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 26, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 26, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 26, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2018 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2017 NREP
REFUSAL PROCESSED BY IB
Oct 21, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 3, 2017 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 1, 2017 RFCR
NON-FINAL ACTION WRITTEN
Sep 30, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 29, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 24, 2017 REPR